NCPA applauds new class action lawsuit against UnitedHealth, OptumRx to recoup DIR fees
The National Community Pharmacists Association praised another class action lawsuit filed against an insurance behemoth and its pharmacy benefit manager that aims to recoup millions of dollars in backdoor fees on small independent pharmacies.
“After years of abuse at the hands of big insurance plans and their PBMs, independent pharmacies are fighting back,” said Douglas Hoey, CEO of NCPA.
The lawsuit, announced by the law firms Berger Montague and Cohen & Gresser, claims that UnitedHealth Group and its PBM, OptumRx, have been assessing pharmacy DIR fees in violation of federal antitrust laws and state laws governing contracts. The plaintiff in the case, Osterhaus Pharmacy of Maquoketa, Iowa, also is the lead plaintiff in a case against CVS Caremark.
[Read more: Pharmacy orgs laud DIR fee and pharmacy access bill as vital for PBM reform]
“It’s very common for individual pharmacies to pay hundreds of thousands of dollars a year in fees that they can’t anticipate, and in many cases long after the point of sale. Moreover, those fees do nothing more than line the pockets of PBMs,” said Hoey. “They’re putting small, independent pharmacies out of business, thereby limiting choice and quality for consumers, and we are optimistic that these legal challenges will finally bring some justice to this self-serving practice. We understand litigation can be uncertain and we are thankful for the bravery of Matt Osterhaus in taking on these 21st century robber barons.”
[Read more: The Future of Pharmacy Care Coalition applauds intro of Senate legislation]
NCPA said, “UnitedHealth Group and OptumRx control nearly a third of all prescriptions in the country, and in some areas, they have a virtual stranglehold on the market. Independent pharmacies whose patients are covered by UnitedHealth must either agree to the shakedown as part of a “take-it-or-leave-it” contract, or they must allow their patients to be steered to a large mail-order pharmacy or some other big competitor that are often affiliated with other insurance companies. Either way, independent pharmacies are pushed to the brink by these practices.”